This report analyzes the worldwide markets for Anti-Obesity Drugs in US$ Million.

The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2024.

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 25 companies including many key and niche players such as -

F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Eisai Co., Ltd.
Novo Nordisk A/S
Rhythm Pharmaceuticals
VIVUS, Inc.